The frustrating slowdown of muscle healing as we age may not be a simple case of failing stem cells, but rather a deliberate survival strategy, according to a new study from UCLA. Researchers have discovered that aging muscle stem cells accumulate a protein called NDRG1, which prioritizes long-term survival over rapid repair. This finding, published in the journal Science, challenges conventional thinking about aging and opens new avenues for developing therapies to boost muscle regeneration in older adults—though with a crucial caveat.
For many, the experience is familiar: a muscle strain that takes weeks to heal, a post-workout soreness that lingers longer, or a slower recovery from injury. Understanding why this happens has been a central question in aging research. The UCLA team, led by Dr. Thomas Rando, director of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA, and postdoctoral scholars Jengmin Kang and Daniel Benjamin, found that the key lies in a molecular shift within the muscle stem cells themselves. Their function suggests that some biological changes linked to aging aren’t necessarily harmful decline, but rather built-in survival mechanisms.
The Role of NDRG1 in Muscle Stem Cell Aging
The research focused on NDRG1, a protein that increases significantly with age in muscle stem cells, reaching levels 3.5 times higher in older cells compared to their younger counterparts. NDRG1 acts as a “brake” on a critical signaling pathway called mTOR, which is essential for activating cells to grow and repair tissue. By dampening mTOR, NDRG1 slows down the activation of stem cells, making them less responsive to injury. This slower response, however, comes with a benefit: it enhances the cells’ ability to survive in the harsher environment of aging muscle. UCLA Newsroom details this discovery.
To test the role of NDRG1, the scientists allowed mice to age naturally—roughly equivalent to 75 human years—and then blocked the protein’s activity. The results were striking. The older muscle stem cells, freed from the NDRG1 brake, began to behave like young cells, activating more quickly and accelerating muscle repair. However, this rejuvenation came at a cost.
A Trade-Off Between Function and Survival
Blocking NDRG1 led to a decrease in the long-term survival of muscle stem cells. Whereas the initial repair was faster, the muscle’s ability to regenerate after repeated injuries was diminished. Dr. Rando explained the dynamic using an analogy: “Think of it like a marathon runner versus a sprinter,” he said. “The stem cells in young animals are hyper-functioning — really quality at what they do, namely sprinting, but they’re not good for the long term. They can make it through the 100-yard dash, but they can’t make it even halfway through the marathon. By contrast, aged stem cells are like marathon runners — slower to respond, but better equipped for the long haul.”
This observation led the researchers to propose the concept of “cellular survivorship bias.” Over time, stem cells that don’t produce enough NDRG1 are more likely to die off, leaving behind a population of cells that are slower to act but more resilient. This isn’t necessarily a failure of aging, but a shift in priorities. As Dr. Rando place it, “Some age-related changes that look detrimental—like slower tissue repair—may actually be necessary compromises that prevent something worse: the complete depletion of the stem cell pool.” ScienceDaily provides further details on this concept.
Implications for Future Therapies
The findings have significant implications for the development of therapies aimed at improving muscle regeneration in older adults. However, Dr. Rando cautions against a simplistic approach. “There’s no free lunch,” he stated. “One can improve the function of aged cells for a period of time, for certain tissues, but every time we do this, there’s going to be a potential cost and a potential downside.” The challenge lies in finding a way to enhance stem cell performance without compromising their long-term survival.
The team’s future research will focus on unraveling the molecular mechanisms that control this delicate balance between survival and regeneration. “This gene is almost like our doorway that we’ve opened into understanding what controls these trade-offs that are so critical, not only for evolution of species but similarly for the aging of tissues within an individual,” Dr. Rando explained. The study was funded by the National Institutes of Health, the NOMIS Foundation, the Milky Way Research Foundation, the Hevolution Foundation and the National Research Foundation of Korea.
This research offers a nuanced perspective on the aging process, suggesting that what appears as decline may, in some cases, be a protective adaptation. While reversing muscle aging remains a complex goal, this new understanding of the role of NDRG1 provides a crucial stepping stone toward developing more effective and sustainable therapies.
Researchers will continue to investigate the intricacies of cellular survival and regeneration, with the next steps focusing on identifying specific targets within the mTOR pathway to potentially modulate the effects of NDRG1. Further studies are planned to explore whether similar mechanisms are at play in other tissues and organs.
What are your thoughts on this new research? Share your comments below, and please share this article with anyone who might find it informative.
